Prateek Choudhary Selected Research

Malaria

1/2018	Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.
12/2017	Role of Activins in Hepcidin Regulation during Malaria.
12/2014	Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
4/2014	Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
1/2014	Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
1/2014	Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
2/2013	Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
12/2012	ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
1/2012	Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Prateek Choudhary Research Topics

Disease

9	Malaria 01/2018 - 01/2012
5	Infections 12/2017 - 12/2012
2	Parasitemia 12/2017 - 01/2014
1	Anemia 12/2017
1	Inflammation (Inflammations) 12/2017
1	Neglected Diseases 12/2014
1	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2014
1	Dementia (Dementias) 05/2013
1	Cognitive Dysfunction 05/2013
1	Alzheimer Disease (Alzheimer's Disease) 05/2013
1	Bites and Stings (Sting) 12/2012

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 12/2014 - 01/2012
4	AntigensIBA 01/2018 - 01/2014
4	Merozoite Surface Protein 1 (MSA1)IBA 04/2014 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2014
3	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 12/2017 - 01/2014
1	ThrombospondinsIBA 01/2018
1	EpitopesIBA 01/2018
1	HepcidinsIBA 12/2017
1	activin AIBA 12/2017
1	Hormones (Hormone)IBA 12/2017
1	IronIBA 12/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2017
1	Activins (Activin)IBA 12/2017
1	activin BIBA 12/2017
1	AluminumIBA 12/2014
1	Aluminum Hydroxide (Algeldrate)FDA Link 12/2014
1	ProMune (CpG 7909)IBA 12/2014
1	Recombinant ProteinsIBA 12/2014
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	LigandsIBA 02/2013
1	Peptides (Polypeptides)IBA 02/2013
1	Malaria VaccinesIBA 12/2012
1	AntibodiesIBA 12/2012